Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Staging classification of malignant lymphoma]

T Takagi1

  • 1Hematology-Chemotherapy Division, Chiba Cancer Center Hospital, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|September 2, 1998
PubMed
Summary

The Ann Arbor staging system effectively classifies Hodgkin's disease and nodal Non-Hodgkin's lymphoma. New classifications are needed for extranodal Non-Hodgkin's lymphoma staging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nucleotide sequence of a complementary DNA for human ST2.

Biochimica et biophysica acta·1992
Same author

Role of liver-type glucose transporter (GLUT2) in transport across the basolateral membrane in rat jejunum.

FEBS letters·1992
Same author

Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis.

Internal medicine (Tokyo, Japan)·1992
Same author

Chromosome condensation caused by loss of RCC1 function requires the cdc25C protein that is located in the cytoplasm.

Molecular biology of the cell·1992
Same author

The atypical M2 segment of the beta subunit confers picrotoxinin resistance to inhibitory glycine receptor channels.

The EMBO journal·1992
Same author

Diastolic vibration improves systolic function in cases of incomplete relaxation.

Circulation·1992

Area of Science:

  • Oncology
  • Hematology
  • Medical Staging Systems

Context:

  • The Ann Arbor staging classification is the standard for Hodgkin's disease.
  • The Cotswolds meeting recommendations are widely adopted for Hodgkin's disease staging.
  • Current staging systems present limitations for Non-Hodgkin's lymphoma, particularly extranodal cases.

Purpose:

  • To evaluate the applicability of the Ann Arbor staging classification for different lymphoma types.
  • To highlight the need for updated staging criteria in extranodal Non-Hodgkin's lymphoma.

Summary:

  • The Ann Arbor staging system is well-established for Hodgkin's disease and nodal Non-Hodgkin's lymphoma.
  • This classification system is limited in its application to extranodal Non-Hodgkin's lymphoma.
  • Specialized staging classifications are recommended for extranodal Non-Hodgkin's lymphoma.

Impact:

  • Clarifies the appropriate use of the Ann Arbor staging system.
  • Underscores the necessity for developing and implementing specific staging guidelines for extranodal lymphomas.
  • Aims to improve diagnostic accuracy and treatment planning for lymphoma patients.

Related Experiment Videos